Investing.com -- Nuvalent Inc (NASDAQ:NUVL) stock fell 3.6% in Monday premarket trading after the clinical-stage biopharmaceutical company released topline pivotal data for its investigational ...
Beneficient (NASDAQ: BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback